GigaCloud Techの空売り状況は、投資家がGigaCloud Techの株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

GigaCloud Tech (NASDAQ:GCT) 株価情報, 空売り情報

GigaCloud Tech

GigaCloud Technology Inc end-to-end B2B e-commerce solutions for large parcel merchandise. Its B2B e-commerce platform, which is referred to as the GigaCloud Marketplace, integrates everything from discovery, payments, and logistics tools into one easy-to-use platform. It offers online and offline integrated cross-border transaction and delivery services for furniture and large merchandise. Its marketplace seamlessly connects manufacturers in Asia, with resellers in the U.S., Asia, and Europe, to execute cross-border transactions with confidence, speed, and efficiency. It offers a truly comprehensive solution that transports products from the manufacturer's warehouse to end customers, all at one fixed price.

GigaCloud Technology Inc - Class A Ordinary Shares

GigaCloud Technology Inc

GlucoTrack Inc

GCT Semiconductor Holding, Inc. Common Stock

GCT Semiconductor Holding Inc

GCT Semiconductor Holding, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50

Expected Milestones in 2025
<ul>
<li>MAD safety, pharmacokinetic and key pharmacodynamic biomarker data in healthy volunteers in the second half of 2025.</li>
<li>GLP toxicity studies of lead ASO candidate for neurodevelopmental disorders caused by SYNGAP1 mutations to be initiated this year.</li>
<li>Advance a new discovery program targeting a GBA1 regRNA to increase gene expression for the treatment of Parkinson's disease (PD) caused by mutations in GBA1, with potential for application in sporadic PD.</li>
<li>Company to focus on expanding its strategic partnerships to continue maximizing the value of its RAP platform.</li>
</ul>

Biotech

News

General

CAMP

CAMP4 Outlines 2025 Milestones: MAD Safety Data in H2, GLP Toxicity Studies for SYNGAP1 Disorders, New GBA1 Discovery for Parkinson's, and Strategic Partnership Expansion.

<ul>
<li>Total sales between $275 million and $279 million;</li>
<li>14 new restaurants, maintaining an annual unit growth rate above 20%, with average net capital expenditures per unit of approximately $2.5 million; and</li>
<li>General and administrative expenses as a percentage of sales to be approximately 13.5%.</li>
</ul>

Guidance

KRUS

Kura Sushi Sees FY25 Sales $275M-$279M Vs $280.04M Estimate

AAR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIR#NYSE">AIR</a>) announced its Q2 earnings on Tuesday, January 7, 2025 at 04:05 PM.
Here's a breakdown of the earnings report.
<h3>Earnings</h3>
AAR beat estimated earnings by 7.000000000000001%, reporting an EPS of $0.9 versus an estimate of $0.84.
Revenue was up $140.70 million from the same period last year.
<h3>Past Earnings Performance</h3>
In the previous quarter, the company beat on EPS by $0.03, resulting in a 5.0% drop change in the share price the following day.
Here's a look at AAR's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.82</td>
<td>0.86</td>
<td>0.84</td>
<td>0.81</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.85</td>
<td>0.88</td>
<td>0.85</td>
<td>0.81</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>645.50M</td>
<td>660.12M</td>
<td>567.63M</td>
<td>558.10M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>661.70M</td>
<td>656.50M</td>
<td>567.30M</td>
<td>545.40M</td>
</tr>
</tbody>
</table>

To track all earnings releases for AAR <a href="https://www.benzinga.com/quote/AIR/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

AAR Earnings Analysis: Q2 Recap

Cal-Maine Foods (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CALM#NASDAQ">CALM</a>) released its Q2 earnings on Tuesday, January 7, 2025 at 04:05 PM.
Here's what's important from the earnings announcement.
<h3>Earnings</h3>
Cal-Maine Foods beat estimated earnings by 21.0%, reporting an EPS of $4.47 versus an estimate of $3.68.
Revenue was up $431.44 million from the same period last year.
<h3>Performance in Previous Earnings</h3>
The company beat on EPS by $0.73 in the last quarter, resulting in a 2.0% drop share price change the following day.
Here's a look at Cal-Maine Foods's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>2.33</td>
<td>1.85</td>
<td>2.46</td>
<td>0.83</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>3.06</td>
<td>2.32</td>
<td>3</td>
<td>0.65</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>614.77M</td>
<td>608.66M</td>
<td>692.35M</td>
<td>525.39M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>785.87M</td>
<td>640.79M</td>
<td>703.08M</td>
<td>523.23M</td>
</tr>
</tbody>
</table>

To track all earnings releases for Cal-Maine Foods <a href="https://www.benzinga.com/quote/CALM/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CALM

Cal-Maine Foods Earnings Report: Q2 Overview

WIIM

AAR Corp shares are trading higher after the company reported better-than-expected Q2 financial results.

Simulations Plus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLP#NASDAQ">SLP</a>) reported quarterly earnings of $0.17 per share which beat the analyst consensus estimate of $0.11 by 54.55 percent. The company reported quarterly sales of $18.90 million which beat the analyst consensus estimate of $18.81 million by 0.50 percent. This is a 30.34 percent increase over sales of $14.50 million the same period last year.

Earnings Beats

Simulations Plus Q1 2025 Adj EPS $0.17 Beats $0.11 Estimate, Sales $18.90M Beat $18.81M Estimate

Kura Sushi USA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KRUS#NASDAQ">KRUS</a>) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.21) by 61.9 percent. The company reported quarterly sales of $64.50 million which beat the analyst consensus estimate of $61.79 million by 4.39 percent. This is a 25.30 percent increase over sales of $51.48 million the same period last year.

Kura Sushi USA Q1 2025 Adj EPS $(0.08) Beats $(0.21) Estimate, Sales $64.50M Beat $61.79M Estimate

The Company's outlook includes completed transaction activity as of December 31, 2024, as well as the issuance and simultaneous repayment of the senior notes referenced above, but does not include assumptions for any prospective acquisitions, dispositions, or capital markets activities.

Getty Realty Establishes Its Initial 2025 AFFO Guidance At $2.40 - $2.42 Per Share; Est $2.42

Contracts

ALSN

Allison Transmission Secures $80.6M Contract For Abrams Tank Program, Covering New And Upgraded Transmissions, Repair Kits, And Technical Support For 2025 Deliveries

SANA

Sana Biotechnology shares are trading higher after the company announced positive clinical trial results from its type 1 diabetes study of islet cell transplantation without immunosuppression.

Cal-Maine Foods shares are trading higher after the company reported better-than-expected Q2 EPS and revenues.

<h3>Gainers</h3>
<ul>
<li>Algorhythm Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIME#NASDAQ">RIME</a>) shares moved upwards by 77.5% to $0.26 during Tuesday's pre-market session. The market value of their outstanding shares is at $24.2 million. </li>
<li>SRIVARU Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SVMH#NASDAQ">SVMH</a>) stock rose 47.73% to $0.07. The market value of their outstanding shares is at $37.4 million. </li>
<li>Emerson Radio (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MSN#AMEX">MSN</a>) shares increased by 26.4% to $0.55. The company's market cap stands at $11.5 million. </li>
<li>Star Equity Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STRR#NASDAQ">STRR</a>) stock rose 23.52% to $2.73. The market value of their outstanding shares is at $8.7 million. </li>
<li>Ambow Education Holding (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AMBO#AMEX">AMBO</a>) shares increased by 14.4% to $2.7. The market value of their outstanding shares is at $7.6 million. </li>
<li>Qurate Retail (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QRTEB#NASDAQ">QRTEB</a>) shares rose 8.98% to $2.79. The market value of their outstanding shares is at $1.1 billion. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Amesite (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMST#NASDAQ">AMST</a>) shares fell 33.3% to $2.7 during Tuesday's pre-market session. The market value of their outstanding shares is at $7.5 million. </li>
<li>Nxu (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXU#NASDAQ">NXU</a>) stock fell 19.61% to $0.82. The market value of their outstanding shares is at $13.6 million. </li>
<li>Serve Robotics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SERV#NASDAQ">SERV</a>) shares decreased by 14.88% to $19.48. The market value of their outstanding shares is at $863.1 million. </li>
<li>1-800-Flowers.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLWS#NASDAQ">FLWS</a>) stock decreased by 8.21% to $7.5. The company's market cap stands at $479.3 million. </li>
<li>Fenbo Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FEBO#NASDAQ">FEBO</a>) stock decreased by 7.59% to $2.07. The company's market cap stands at $22.8 million. </li>
<li>Sacks Parente Golf (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPGC#NASDAQ">SPGC</a>) stock decreased by 6.14% to $0.47. The market value of their outstanding shares is at $4.1 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

AMBO

AMST

FEBO

FLWS

QRTEB

RIME

SERV

SPGC

STRR

SVMH

12 Consumer Discretionary Stocks Moving In Tuesday's Pre-Market Session

AAR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIR#NYSE">AIR</a>) reported quarterly earnings of $0.90 per share which beat the analyst consensus estimate of $0.84 by 7.14 percent. This is a 11.11 percent increase over earnings of $0.81 per share from the same period last year. The company reported quarterly sales of $686.10 million which beat the analyst consensus estimate of $654.18 million by 4.88 percent. This is a 25.80 percent increase over sales of $545.40 million the same period last year.

AAR Q2 Adj $0.90 Beats $0.84 Estimate, Sales $686.10M Beat $654.18M Estimate

<h3>Gainers</h3>
<ul>
<li>Hoth Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOTH#NASDAQ">HOTH</a>) shares rose 106.2% to $1.69 during Tuesday's pre-market session. The market value of their outstanding shares is at $11.6 million. </li>
<li>Conduit Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDT#NASDAQ">CDT</a>) shares increased by 68.74% to $0.12. The company's market cap stands at $14.6 million. </li>
<li>Immuneering (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMRX#NASDAQ">IMRX</a>) stock moved upwards by 57.62% to $3.72. The company's market cap stands at $115.5 million. </li>
<li>Syra Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYRA#NASDAQ">SYRA</a>) shares rose 32.6% to $0.65. The market value of their outstanding shares is at $6.3 million. </li>
<li>Cormedix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRMD#NASDAQ">CRMD</a>) shares moved upwards by 27.36% to $10.1. The market value of their outstanding shares is at $612.8 million. </li>
<li>Inari Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NARI#NASDAQ">NARI</a>) stock rose 21.49% to $78.97. The company's market cap stands at $4.6 billion. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Regional Health Props (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/RHE#AMEX">RHE</a>) stock fell 23.0% to $2.74 during Tuesday's pre-market session. The company's market cap stands at $5.1 million. </li>
<li>Ainos (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIMD#NASDAQ">AIMD</a>) shares declined by 15.76% to $0.69. The market value of their outstanding shares is at $9.7 million. </li>
<li>Enveric Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENVB#NASDAQ">ENVB</a>) shares decreased by 15.15% to $0.36. The market value of their outstanding shares is at $3.6 million. </li>
<li>DIH Holding US (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DHAI#NASDAQ">DHAI</a>) stock declined by 14.73% to $2.49. The company's market cap stands at $100.9 million. </li>
<li>Onconetix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONCO#NASDAQ">ONCO</a>) stock declined by 13.72% to $0.61. The company's market cap stands at $5.0 million. </li>
<li>Healthcare Triangle (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCTI#NASDAQ">HCTI</a>) stock fell 13.53% to $1.47. The market value of their outstanding shares is at $8.3 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AIMD

CRMD

DHAI

ENVB

HCTI

HOTH

IMRX

NARI

ONCO

SYRA

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Sana Biotechnology Announces Clinical Results From Type 1 Diabetes Study Of Islet Cell Transplantation Without Immunosuppression

<h3>Gainers</h3>
<ul>
<li>UniFirst (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNF#NYSE">UNF</a>) stock moved upwards by 40.5% to $237.98 during Tuesday's pre-market session. The company's market cap stands at $4.4 billion. </li>
<li>CEA Industries (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CEAD#NASDAQ">CEAD</a>) stock moved upwards by 18.81% to $9.22. The company's market cap stands at $7.2 million. </li>
<li>Enovix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENVX#NASDAQ">ENVX</a>) shares moved upwards by 13.72% to $14.17. The company's market cap stands at $2.6 billion. </li>
<li>Bridger Aerospace Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BAER#NASDAQ">BAER</a>) stock increased by 11.24% to $2.77. The market value of their outstanding shares is at $150.0 million. </li>
<li>Zeo Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZEO#NASDAQ">ZEO</a>) shares rose 10.03% to $2.85. The market value of their outstanding shares is at $39.5 million. </li>
<li>Staffing 360 Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STAF#NASDAQ">STAF</a>) stock increased by 9.42% to $2.67. The company's market cap stands at $4.0 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Guardforce AI Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GFAI#NASDAQ">GFAI</a>) stock decreased by 17.7% to $2.46 during Tuesday's pre-market session. The market value of their outstanding shares is at $29.1 million. </li>
<li>Samfine Creation Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFHG#NASDAQ">SFHG</a>) stock declined by 16.17% to $1.4. The company's market cap stands at $31.2 million. </li>
<li>Energous (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WATT#NASDAQ">WATT</a>) shares decreased by 13.83% to $1.06. The market value of their outstanding shares is at $10.7 million. </li>
<li>Servotronics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SVT#AMEX">SVT</a>) shares declined by 13.64% to $9.5. The company's market cap stands at $24.2 million. </li>
<li>GEE Group (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/JOB#AMEX">JOB</a>) shares fell 11.74% to $0.25. The market value of their outstanding shares is at $26.9 million. </li>
<li>Ocean Power Techs (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/OPTT#AMEX">OPTT</a>) stock declined by 11.19% to $1.43. The company's market cap stands at $208.8 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BAER

CEA INDUSTRIES INC by CEA Industries Inc.

CEAD

ENVX

GFAI

OPTT

SFHG

STAF

WATT

12 Industrials Stocks Moving In Tuesday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>XTI Aerospace (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XTIA#NASDAQ">XTIA</a>) shares rose 139.9% to $0.21 during Tuesday's pre-market session. The company's market cap stands at $62.1 million. </li>
<li>MultiSensor AI Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSAI#NASDAQ">MSAI</a>) stock moved upwards by 56.0% to $3.12. The company's market cap stands at $94.9 million. </li>
<li>Aurora Innovation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUR#NASDAQ">AUR</a>) shares moved upwards by 38.92% to $9.03. The company's market cap stands at $15.5 billion. </li>
<li>DatChat (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DATS#NASDAQ">DATS</a>) stock increased by 21.42% to $2.38. The market value of their outstanding shares is at $7.1 million. </li>
<li>BIO-key Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKYI#NASDAQ">BKYI</a>) shares moved upwards by 16.23% to $1.79. The company's market cap stands at $5.5 million. </li>
<li>Wellchange Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WCT#NASDAQ">WCT</a>) stock moved upwards by 16.17% to $1.58. The company's market cap stands at $33.5 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Boxlight (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BOXL#NASDAQ">BOXL</a>) stock declined by 24.6% to $1.27 during Tuesday's pre-market session. The market value of their outstanding shares is at $12.4 million. </li>
<li>Focus Universal (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FCUV#NASDAQ">FCUV</a>) stock fell 16.37% to $0.81. The market value of their outstanding shares is at $60.0 million. </li>
<li>MicroCloud Hologram (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOLO#NASDAQ">HOLO</a>) stock fell 12.5% to $3.43. The market value of their outstanding shares is at $70.4 million. </li>
<li>AmpliTech Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMPG#NASDAQ">AMPG</a>) stock decreased by 12.32% to $3.49. The company's market cap stands at $68.6 million. </li>
<li>SMX (Security Matters) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMX#NASDAQ">SMX</a>) shares decreased by 9.27% to $0.42. The market value of their outstanding shares is at $1.2 million. </li>
<li>Intrusion (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTZ#NASDAQ">INTZ</a>) shares fell 9.15% to $2.88. The market value of their outstanding shares is at $25.0 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AMPG

BKYI

BOXL

DATS

FCUV

MicroCloud Hologram Inc. - Ordinary Shares

HOLO

INTZ

Infrared Cameras Holdings, Inc. - Common Stock

MSAI

XTIA

12 Information Technology Stocks Moving In Tuesday's Pre-Market Session

Cal-Maine Foods (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CALM#NASDAQ">CALM</a>) reported quarterly earnings of $4.47 per share which beat the analyst consensus estimate of $4.25 by 5.18 percent. The company reported quarterly sales of $954.700 million which beat the analyst consensus estimate of $751.495 million by 27.04 percent. This is a 82.46 percent increase over sales of $523.234 million the same period last year.

Cal-Maine Foods Q2 2025 GAAP EPS $4.47 Beats $4.25 Estimate, Sales $954.700M Beat $751.495M Estimate

Kimbell Royalty To Acquire Mineral And Royalty Interest At Midland Basin For $231M

Full year revenue of ~$84.6 million represents a 15% year-over-year increase
Cash balance of ~$185.0 million expected to provide runway to cash flow break-even
Personalis, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSNL#NASDAQ">PSNL</a>), a leader in advanced genomics for precision oncology, today reported unaudited preliminary revenue for the fourth quarter and full year ended December 31, 2024 and preliminary cash balance.
Preliminary Full Year 2024 Revenue
<ul>
<li>Revenue of approximately $84.6 million for the full year of 2024 compared with $73.5 million for the full year of 2023, an increase of 15%, and above the company's previous full year guidance range of $83.0 to $84.0 million</li>
<li>Revenue from pharma tests and services, enterprise sales, and other customers of approximately $77.2 million for the full year of 2024 compared with $64.1 million for the full year of 2023, an increase of 20%, despite revenue from Natera decreasing 20% to approximately $25.4 million for the full year of 2024</li>
<li>Revenue from population sequencing for the U.S. Department of Veterans Affairs Million Veterans Program (VA MVP) of approximately $7.4 million for the full year of 2024, compared with $9.4 million for the full year of 2023, a decrease of 21%</li>
</ul>
Preliminary Fourth Quarter Revenue, Cash Balance, and Clinical Volume
<ul>
<li>Revenue of approximately $16.8 million for the fourth quarter of 2024 compared with $19.7 million for the fourth quarter of 2023, a decrease of 15%, primarily due to the expected decline in revenue from Natera and the VA MVP</li>
<li>Revenue from pharma tests and services, enterprise sales, and other customers of approximately $16.6 million for the fourth quarter of 2024 compared with $18.7 million for the fourth quarter of 2023, a decrease of 11%, which includes the expected decrease in revenue from Natera of 41% to approximately $4.2 million for the fourth quarter of 2024</li>
<li>Cash, cash equivalents, and short-term investments of approximately $185.0 million as of December 31, 2024; includes the $50 million strategic investment from Merck</li>
<li>Delivered 1,441 total molecular tests in the fourth quarter of 2024, an increase of 52% compared with 945 tests delivered in the third quarter of 2024</li>
</ul>

PSNL

Personalis Reports Preliminary Q4 Revenue Of $16.8M Down From $19.7M YoY; FY24 Revenue Of $84.6M Up From $73.5M YoY

Morgan Stanley is acting as sole book running manager for the offering. Published first on TheFly – the ultimate source for real-time, market-movin...

GigaCloud 2.6M share Spot Secondary; price range $22.20-$22.50

Bullish option flow detected in GigaCloud (GCT) Technology with 11,009 calls trading, 5x expected, and implied vol increasing almost 6 points to 75...

GigaCloud Technology call volume above normal and directionally bullish

GigaCloud Is Discounted For Good Reasons - Reiterate Hold

GigaCloud: Buying Opportunity On Its Unjustified Meltdown

How Steven Cress' Top 10 2024 Picks Have Fared

GigaCloud: U.S. Tariffs On Chinese Imports Cast A Dark Cloud Over This B2B Platform

Bullish option flow detected in GigaCloud (GCT) Technology with 2,534 calls trading, 2x expected, and implied vol increasing almost 6 points to 66....

GigaCloud Technology pops as director buys shares

2024 Performance Review & Lessons Learnt, +34% Annual Return, +40% CAGR In 5 Years

Bullish option flow detected in GigaCloud (GCT) Technology with 9,814 calls trading, 3x expected, and implied vol increasing almost 7 points to 71....

AAPL

ADFJF

AMZN

BIRDF

BKNG

DJIA

GASS

GOOG

GOOGL

HSHP

IITSF

ISNPY

MNSO

NVDA

OPFI

PHXHF

RLLCF

RYCEF

RYCEY

SMCI

TSLA

ZDGE

Press Releases

GigaCloud Technology Inc Joins Russell 2000 Index

GigaCloud Technology Inc to Announce Second Quarter and First Half 2024 Financial Results on August 6, 2024

GigaCloud Technology Inc Announces Second Quarter and Six Months Ended June 30, 2024 Financial Results

Management

GigaCloud Technology Inc Announces CFO Transition

GigaCloud Technology Inc Announces $46 Million Share Repurchase Program

GigaCloud Technology Inc to Announce Third Quarter 2024 Financial Results and Host Conference Call on November 7, 2024

GigaCloud Technology Inc Announces Third Quarter and Nine Months Ended September 30, 2024 Financial Results

GigaCloud Technology Inc Welcomes Industry Veteran Marshall Bernes to Board

GigaCloud Technology Inc Ranked No. 1 on Forbes' List of 'America's Most Successful Small-Cap Companies 2025'

GigaCloud Technology Inc Secures Multiple Wins in Furniture Today's 2024 Reader Rankings for Second Consecutive Year

Comments

GigaCloud Tech

空売り

GigaCloud Tech (NASDAQ:GCT) 株価情報, 空売り情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル